Search Results 251-260 of 1815 for Tracleer
The Parkinson Progression Marker Initiative (PPMI) is a study to assess progression of clinical features, digital outcomes, and imaging, biologic and ...
Tagliero LE, Munaretto N, Lenartowicz K, Shin A, Bishop A, Moran SL, Kakar S. Treatment Options for Coronal Plane Fractures of the Lunate in Kienbock ...
Rochester, Minn. The purpose of this study is to collect blood samples for DNA analysis from patients clinically diagnosed with Alzheimers disease, Lewy Body ...
One uncontrolled, unpublished study suggests that a footstool improved bowel symptoms in nearly 98% of 153 constipated participants. The purpose of this study ...
Among persons with Immunoglobulin G subclass 4 Related Disease (IgG4)-related disease who have persistent or recurrent disease despite standard therapies, does ...
Patrick P. Starlinger, M.D., Ph.D., a hepatobiliary and pancreas surgeon at Mayo Clinic in Rochester, MN, offers advanced liver, bile duct, and pancreatic ...
Mayo Clinic Oncology — Medical oncologists at Mayo Clinic offer innovative treatments for cancers of the organs, bones, muscles and connective tissues.
The purpose of phase 1 of this trial is to determine the maximum tolerated dose of temozolomide followed by selinexor in recurrent glioblastoma patients as ...
A Study to Examine the Long-Term Safety, Tolerability and Effectiveness of APL-130277 for the Acute Treatment of "OFF" Episodes in Patients with Parkinson's ...
The purpose of the study is to determine the best dose of CC-486 (oral azacitidine) combined with pembrolizumab for the treatment of platinum-resistant ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.